GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 296 filers reported holding GUARDANT HEALTH INC in Q3 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $955,534 | -15.4% | 32,238 | +2.1% | 0.00% | -33.3% |
Q2 2023 | $1,130,134 | -57.8% | 31,568 | -72.3% | 0.00% | -50.0% |
Q1 2023 | $2,675,091 | -13.8% | 114,125 | 0.0% | 0.01% | -25.0% |
Q4 2022 | $3,104,200 | -51.5% | 114,125 | -4.0% | 0.01% | -50.0% |
Q3 2022 | $6,402,000 | +32.3% | 118,935 | -0.8% | 0.02% | +33.3% |
Q2 2022 | $4,838,000 | -30.5% | 119,925 | +14.1% | 0.01% | -7.7% |
Q1 2022 | $6,962,000 | -34.9% | 105,103 | -1.7% | 0.01% | -31.6% |
Q4 2021 | $10,690,000 | -19.5% | 106,877 | +0.6% | 0.02% | -26.9% |
Q3 2021 | $13,276,000 | +0.7% | 106,196 | +0.0% | 0.03% | +4.0% |
Q2 2021 | $13,187,000 | -14.7% | 106,181 | +4.8% | 0.02% | -19.4% |
Q1 2021 | $15,462,000 | +15.7% | 101,291 | -2.3% | 0.03% | +14.8% |
Q4 2020 | $13,359,000 | +32.4% | 103,651 | +14.8% | 0.03% | +17.4% |
Q3 2020 | $10,093,000 | +44.5% | 90,293 | +4.9% | 0.02% | +35.3% |
Q2 2020 | $6,986,000 | +135.5% | 86,113 | +102.0% | 0.02% | +88.9% |
Q1 2020 | $2,966,000 | -0.2% | 42,622 | +12.1% | 0.01% | +28.6% |
Q4 2019 | $2,972,000 | +89.8% | 38,035 | +55.0% | 0.01% | +75.0% |
Q3 2019 | $1,566,000 | -18.1% | 24,535 | +10.8% | 0.00% | -20.0% |
Q2 2019 | $1,911,000 | – | 22,135 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |